About Us

Hieroglyph Digital Technology Limited (“HIEROGLYPH”) is a blockchain innovation company,
providing institutions and their data assets with encryption, storage and management services.

Secure the Distributed Data Assets

Store Data with Lower Costs and Easier Accessibility

Exploit the Value of Data Assets and Increase Liquidity

Build up the Future of the Blockchain Data Asset Ecosystem

   

   

OUR VISION

 

Create a secure data environment for
health, education, and economic sustainability

Promote a safer, fairer, more effective society,
and a more harmonious and beautiful life for people

Our Solutions

Adopting Blockchain technology, We provide encryption, storage
and management services to take care of our clients’ data assets.

Data Storage Platform

This platform is designed based on Blockchain technology. We aim at creating an user-friendly tool to store and protect our clients’ data assets.

Learn more…

Data Management Service

We provide data management service to allow our users to manage their data assets. This service focuses on exploring the value of data for achieving transfer and exchange of data assets.

Learn more…

Bitcoin Blockchain Data Service

Our Bitcoin data service provides processing of Bitcoin blockchain data, and focusing on the analysis of transaction activities.

Learn more…

APPLICATION FIELD

 

Financial Service

A safe trust mechanism between financial services

Improve the efficiency of operations
Ensure the authenticity of transaction data
Realize the value and liquidity of digital assets

Academic Research

Protect research data for academic institutions

Prevent academic misconduct
Secure research originality

Civil Governance

Serve local governments for civil affairs managements

Streamline the workflow
Reduce labor costs
Enhance the mutual trust between citizens and officials

Healthcare & Drug Development

Secure big data in healthcare

Meet the industry’s needs for data security, clinical
research specification, ethical supervision
Optimize efficiency in the module of clinical research
on new drug development